| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013629 |
| Receipt No. | R000015684 |
| Official scientific title of the study | Injection laryngoplasty using basic fibroblast growth factor for the treatment of deficient glottal closure |
| Date of disclosure of the study information | 2014/04/04 |
| Last modified on | 2016/04/04 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Injection laryngoplasty using basic fibroblast growth factor for the treatment of deficient glottal closure | |
| Title of the study (Brief title) | Injection laryngoplasty using basic fibroblast growth factor for the treatment of deficient glottal closure | |
| Region |
|
|
| Condition | ||
| Condition | deficient glottal closure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To analyze the effects of bFGF injection for deficient glottal closure |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | High speed imaging and acoustic analysis |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | basic fibroblastgrowth factor | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | deficiencies in glottal closure | |||
| Key exclusion criteria | Patient with the past of the malignant tumor | |||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Kiyoshi Makiyama |
| Organization | Nihon university,School of Medicine |
| Division name | Otorhinolaryngorogy-Head and Neck surgery |
| Address | 30-1 Oyaguchi kamithyo,Itabashiku,Tokyo |
| TEL | 03-3972-8111 |
| mak@med.email.ne.jp | |
| Public contact | |
| Name of contact person | Suzuki Hirotaka |
| Organization | Nihon university,School of Medicine |
| Division name | Otorhinolaryngorogy-Head and Neck surgery |
| Address | 30-1 Oyaguchi kamithyo,Itabashiku,Tokyo |
| TEL | 03-3972-8111 |
| Homepage URL | |
| hirotaka.0624@gmail.com | |
| Sponsor | |
| Institute | Nihon University Surugadai Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | grant-in-aid for scientific research |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 駿河台日本大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/icdr_e/ctr_view.cgi?recptno=R000015684 |